Abstract
Background Hepatitis B e antigen (HBeAg) seroclearance has been considered as the treatment endpoint in HBeAg-positive patients with chronic hepatitis......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
